Resveratrol, a SIRT1 inducer, affords protection in GBM/GSC and has recently been proposed as an adjunctive in GBM/GSC treatment[148], with the induction of SIRT1 having effects that include regulation of the GBM/GSC microenvironment[149]. The gene discussed is SIRT1; the disease is glioblastoma.